A study has identified the key role of lateral septum neurons in the effects of the anti-obesity drug liraglutide, offering ...
The growth of highly sought-after weight-loss drugs like Wegovy and Ozempic, otherwise known as GLP-1 medications, represents a shift in obesity management.
Hosted on MSN17h
The economic cost of obesity is expected to soar to $4 trillion by 2035. Weight loss drugs like Ozempic could change that, Goldman Sachs says.Novo Nordisk became the biggest European company, as measured by market value, earlier this week, so investors are starting to catch on. "We see anti-obesity drugs as one of the biggest drug classes ...
We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...
The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence ...
As film festival season gathers pace, the 68th BFI London Film Festival (LFF) has announced its full 2024 programme, ...
Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.
Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on September 6 and set a price ...
Children's health is facing a deadly crisis, with life-threatening illnesses, obesity, eating disorders, and infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results